Quibron-t

   
Google
 
Web NewDrugInformation.com

Quibron-t


Drug - Quibron-t
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Theophylline
Multiple ingredients are in alphabetical order.

Strength - 300MG
The potency of the active ingredient(s), Theophylline. May repeat for multiple part products.

Applicant - MONARCH PHARMS
The firm name holding legal responsibility for Quibron-t. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088656
The FDA assigned number to Quibron-t. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Quibron-t. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 22, 1985
The date Quibron-t was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Quibron-t. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Quibron-t is in. Format is RX, OTC, DISCN.

Applicant Full Name - Monarch Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Quibron-t.

Quibron-t